{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T22:58:40Z","timestamp":1648508320846},"reference-count":5,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.leukres.2013.09.004","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T12:31:59Z","timestamp":1379075519000},"page":"1438-1439","source":"Crossref","is-referenced-by-count":0,"title":["Unravelling survival pathways: The road to next-generation chronic myeloid leukaemia drugs?"],"prefix":"10.1016","volume":"37","author":[{"given":"Dries","family":"Deeren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2013.09.004_bib0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11899-012-0148-8","article-title":"Targeting chronic myeloid leukemia stem cells","volume":"8","author":"Kinstrie","year":"2013","journal-title":"Curr Hematol Malign Rep"},{"key":"10.1016\/j.leukres.2013.09.004_bib0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11899-012-0152-z","article-title":"Role of epigenetics in chronic myeloid leukemia","volume":"8","author":"Machova Polakova","year":"2013","journal-title":"Curr Hematol Malign Rep"},{"key":"10.1016\/j.leukres.2013.09.004_bib0015","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1158\/1078-0432.CCR-10-1613","article-title":"Molecular pathways: BCR-ABL","volume":"18","author":"Cilloni","year":"2012","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.leukres.2013.09.004_bib0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11899-012-0150-1","article-title":"Signal transduction in the chronic leukemias: implications for targeted therapies","volume":"8","author":"Ahmed","year":"2013","journal-title":"Curr Hematol Malign Rep"},{"key":"10.1016\/j.leukres.2013.09.004_bib0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.stem.2012.03.006","article-title":"Targeting beta-catenin in CML: leukemia stem cells beware!","volume":"10","author":"Kleppe","year":"2012","journal-title":"Cell Stem Cell"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613003214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212613003214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T23:54:42Z","timestamp":1539388482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212613003214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":5,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0145212613003214"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2013.09.004","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}